Table 2.
Knowledge Assessment of Women at All Sites
| Parameter | AIIMS ND Site 1 N (%) |
GKNM Site 2 N (%) |
AIIMS R Site 3 N (%) |
PGIMER Site 4 N (%) |
SJH Site 5 N (%) |
MGIMS Site 6 N (%) |
Total N (%) |
|---|---|---|---|---|---|---|---|
| Heard of cervical cancer | 124 (41.3) | 189 (63.0) | 282 (94.0) | 69 (23.0) | 7 (2.3) | 152 (50.7) | 823 (45.7) |
| Symptoms of cervical cancer | |||||||
| Postmenopausal Bleeding | 08 (2.7) | 40 (13.3) | 0 (0.0) | 11 (3.67) | 0 (0.0) | 28 (9.3) | 87 (4.8) |
| Postcoital bleeding | 05 (1.7) | 05 (1.7) | 33 (11.0) | 02 (0.7) | 01 (0.3) | 57 (19.0) | 103 (5.7) |
| Intermenstrual bleeding | 20 (6.7) | 24 (8.0) | 45 (15.0) | 04 (1.3) | 00 (0.0) | 11 (3.7) | 104 (5.7) |
| Vaginal discharge | 24 (8.0) | 33 (11.0) | 42 (14.0) | 05 (1.7) | 00 (0.0) | 120 (40.0) | 224 (12.4) |
| Hematuria | 04 (1.3) | 09 (3.0) | 05 (1.7) | 08 (2.7) | 00 (0.0) | 24 (8.0) | 50 (2.8) |
| Weight loss | 05 (1.7) | 18 (6.0) | 01 (0.3) | 01 (0.3) | 00 (0.0) | 01 (0.3) | 26 (1.4) |
| Risk Factors | |||||||
| Multiparity | 04 (1.3) | 10 (3.3) | 00 (0.0) | 15 (5.0) | 01 (0.3) | 50 (16.7) | 80 (4.4) |
| Prolonged oral contraceptives | 05 (1.7) | 28 (9.3) | 00 (0.0) | 03 (1.0) | 00 (0.0) | 79 (26.3) | 115 (6.4) |
| HPV infection | 07 (2.3) | 26 (8.7) | 18 (6.0) | 03 (1.0) | 00 (0.0) | 00 (0.0) | 54 (3.0) |
| Early marriage | 06 (2.0) | 15 (5.0) | 02 (0.7) | 32 (10.7) | 00 (0.0) | 25 (8.3) | 80 (4.4) |
| Smoking | 03 (1.0) | 11 (3.67) | 30 (10.0) | 03 (1.0) | 00 (0.0) | 22 (7.3) | 69 (3.8) |
| Poor menstrual hygiene | 07 (2.3) | 17 (5.7) | 31 (10.3) | 05 (1.7) | 00 (0.0) | 58 (19.3) | 118 (6.5) |
| Reduced immunity (HIV/Transplant patients) | 02 (0.7) | 16 (5.3) | 00 (0.0) | 00 (0.0) | 00 (0.0) | 01 (0.3) | 19 (1.1) |
| Heard that cervical cancer is preventable | 51 (17.0) | 164 (54.7) | 48 (16.0) | 19 (6.3) | 03 (1.0) | 111 (37.0) | 396 (22.0) |
| Preventive measures for cervical cancer | |||||||
| Cervical CA screening | 24 (47.1) | 99 (60.4) | 21 (43.8) | 11 (57.9) | 01 (33.3) | 64 (57.7) | 220 (55.6) |
| HPV vaccination | 10 (19.6) | 22 (13.4) | 11 (22.9) | 01 (5.3) | 01 (33.3) | 25 (22.5) | 70 (17.7) |
| Avoiding risk factors | 02 (3.92) | 02 (1.2) | 00 (0.0) | 01 (5.3) | 00 (0.0) | 18 (16.2) | 23 (5.8) |
HIV, Human Immunodeficiency Virus; HPV, Human Papilloma Virus